Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joachim Brumberg

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
JAMA Network Open|April 21, 2021
Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral CavityChristian Linz, Roman C Brands, Theresia Herterich, et al.
Clinical Nuclear Medicine|July 6, 2019
Clinical Utility of Different Approaches for Detection of Late Pseudoprogression in Glioblastoma With O-(2-[18F]Fluoroethyl)-L-Tyrosine PETOlivia Kertels, Milena I Mihovilovic, Thomas Linsenmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 29, 2021
Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity - initial experience and comparison to [<sup>18</sup>F]FDG PET/CT and MRIChristian Linz, Roman C Brands, Olivia Kertels, et al.
Annals of Clinical and Translational Neurology|September 15, 2017
Cholinergic activity and levodopa-induced dyskinesia: a multitracer molecular imaging studyJoachim Brumberg, Sebastian Küsters, Ehab Al-Momani, et al.
Acta Neuropathologica|February 10, 2017
Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's diseaseKathrin Doppler, Hanna-Maria Jentschke, Lena Schulmeyer, et al.
Neuroimage. Clinical|August 21, 2022
Unravelling delayed therapy escape after thalamic deep brain stimulation for essential tremor? - Additional clinical and neuroimaging evidenceBastian E A Sajonz, Marvin L Frommer, Isabelle D Walz, et al.
Frontiers in Immunology|September 10, 2025
Case Report: Acute polymorphic psychosis and NMDA-R IgG antibodies in serum: a follow-up case studyKatharina von Zedtwitz, Judith Weiser, Raphael J Dressle, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 27, 2022
Quantification of the purinergic P2X<sub>7</sub> receptor with [<sup>11</sup>C]SMW139 improves through correction for brain-penetrating radiometabolitesJoachim Brumberg, Richard Aarnio, Anton Forsberg, et al.
Journal of Neuroimmunology|July 5, 2025
Association of ADHD symptoms, pain, and tics with anti-thalamus antibodies in cerebrospinal fluidDominique Endres, Katharina von Zedtwitz, Alexander Rau, et al.
Frontiers in Aging Neuroscience|September 2, 2014
Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's diseaseIoannis Ugo Isaias, Jörg Spiegel, Joachim Brumberg, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
JAMA Network Open|April 21, 2021
Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral CavityChristian Linz, Roman C Brands, Theresia Herterich, et al.
Clinical Nuclear Medicine|July 6, 2019
Clinical Utility of Different Approaches for Detection of Late Pseudoprogression in Glioblastoma With O-(2-[18F]Fluoroethyl)-L-Tyrosine PETOlivia Kertels, Milena I Mihovilovic, Thomas Linsenmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 29, 2021
Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity - initial experience and comparison to [<sup>18</sup>F]FDG PET/CT and MRIChristian Linz, Roman C Brands, Olivia Kertels, et al.
Annals of Clinical and Translational Neurology|September 15, 2017
Cholinergic activity and levodopa-induced dyskinesia: a multitracer molecular imaging studyJoachim Brumberg, Sebastian Küsters, Ehab Al-Momani, et al.
Acta Neuropathologica|February 10, 2017
Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's diseaseKathrin Doppler, Hanna-Maria Jentschke, Lena Schulmeyer, et al.
Neuroimage. Clinical|August 21, 2022
Unravelling delayed therapy escape after thalamic deep brain stimulation for essential tremor? - Additional clinical and neuroimaging evidenceBastian E A Sajonz, Marvin L Frommer, Isabelle D Walz, et al.
Frontiers in Immunology|September 10, 2025
Case Report: Acute polymorphic psychosis and NMDA-R IgG antibodies in serum: a follow-up case studyKatharina von Zedtwitz, Judith Weiser, Raphael J Dressle, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 27, 2022
Quantification of the purinergic P2X<sub>7</sub> receptor with [<sup>11</sup>C]SMW139 improves through correction for brain-penetrating radiometabolitesJoachim Brumberg, Richard Aarnio, Anton Forsberg, et al.
Journal of Neuroimmunology|July 5, 2025
Association of ADHD symptoms, pain, and tics with anti-thalamus antibodies in cerebrospinal fluidDominique Endres, Katharina von Zedtwitz, Alexander Rau, et al.
Frontiers in Aging Neuroscience|September 2, 2014
Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's diseaseIoannis Ugo Isaias, Jörg Spiegel, Joachim Brumberg, et al.
Pageof 6